Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease

References

• Nitsa A, Toutouza M, Machairas N, Mariolis A, Philippou A, Koutsilieris M. Vitamin D in cardiovascular disease. In Vivo (Brooklyn). 2018;32(5):977–981. doi:10.21873/invivo.11338
   PubMed Web of Science ®Google Scholar
• Roth GA, Johnson C, Abajobir A, et al. Global, regional, and National Burden of Cardiovascular Diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
   PubMed Web of Science ®Google Scholar
• Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787–8803. doi:10.3748/wjg.v21.i29.8787
   PubMed Web of Science ®Google Scholar
• Heintz-Buschart A, Wilmes P. Human gut microbiome: function matters. Trends Microbiol. 2018;26(7):563–574. doi:10.1016/j.tim.2017.11.002
   PubMed Web of Science ®Google Scholar
• Wampach L, Heintz-Buschart A, Hogan A, et al. Colonization and succession within the human gut microbiome by archaea, bacteria, and microeukaryotes during the first year of life. Front Microbiol. 2017;8:738. doi:10.3389/fmicb.2017.00738
   PubMed Web of Science ®Google Scholar
• Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–1638. doi:10.1126/science.1110591
   PubMed Web of Science ®Google Scholar
• Demarquoy J, Georges B, Rigault C, et al. Radioisotopic determination of l-carnitine content in foods commonly eaten in Western countries. Food Chem. 2004;86(1):137–142. doi:10.1016/j.foodchem.2003.09.023
   Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell. 2016;164(3):337–340. doi:10.1016/j.cell.2016.01.013
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821
   PubMed Web of Science ®Google Scholar
• Lim ES, Zhou Y, Zhao G, et al. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med. 2015;21(10):1228–1234. doi:10.1038/nm.3950
   PubMed Web of Science ®Google Scholar
• Martinez-Guryn K, Leone V, Chang EB. Regional diversity of the gastrointestinal microbiome. Cell Host Microbe. 2019;26(3):314–324. doi:10.1016/j.chom.2019.08.011
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, de la Visitación N, et al. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects. Br J Pharmacol. 2020;177(9):2006–2023. doi:10.1111/bph.14965
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, Romero M, et al. Antihypertensive effects of probiotics. Curr Hypertens Rep. 2017;19(4):26. doi:10.1007/s11906-017-0723-4
   PubMed Web of Science ®Google Scholar
• Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331–1340. doi:10.1161/HYPERTENSIONAHA.115.05315
   PubMed Web of Science ®Google Scholar
• Hoyles L, Jiménez-Pranteda ML, Chilloux J, et al. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota. Microbiome. 2018;6(1):73. doi:10.1186/s40168-018-0461-0
   PubMed Web of Science ®Google Scholar
• Ufnal M, Jazwiec R, Dadlez M, Drapala A, Sikora M, Skrzypecki J. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. Can J Cardiol. 2014;30(12):1700–1705. doi:10.1016/j.cjca.2014.09.010
   PubMed Web of Science ®Google Scholar
• D’Odorico I, Di Bella S, Monticelli J, Giacobbe DR, Boldock E, Luzzati R. Role of fecal microbiota transplantation in inflammatory bowel disease. J Dig Dis. 2018;19(6):322–334. doi:10.1111/1751-2980.12603
   PubMed Web of Science ®Google Scholar
• Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate. World J Gastroenterol. 2016;22(32):7186–7202. doi:10.3748/wjg.v22.i32.7186
   PubMed Web of Science ®Google Scholar
• Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015;66:343–359. doi:10.1146/annurev-med-060513-093205
   PubMed Web of Science ®Google Scholar
• Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63. doi:10.1038/nature09922
   PubMed Web of Science ®Google Scholar
• Yan G, Wang J, Yi T, et al. Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF-κB signaling pathways. Pulm Circ. 2019;9(4):2045894019878599. doi:10.1177/2045894019878599
   Web of Science ®Google Scholar
• Seldin MM, Meng Y, Qi H, et al. Trimethylamine N-Oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear Factor-κB. J Am Heart Assoc. 2016;5(2). doi:10.1161/JAHA.115.002767
   PubMed Web of Science ®Google Scholar
• Yang G, Lin CC, Yang Y, et al. Nobiletin prevents trimethylamine oxide-induced vascular inflammation via inhibition of the NF-κB/MAPK pathways. J Agric Food Chem. 2019;67(22):6169–6176. doi:10.1021/acs.jafc.9b01270
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y, Antony V, Sun H, Liang G. Metabolism-Associated Molecular Patterns (MAMPs). Trends Endocrinol Metab. 2020;31(10):712–724. doi:10.1016/j.tem.2020.07.001
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhang X, Zhao Y, Yang X. High l-Carnitine ingestion impairs liver function by disordering gut bacteria composition in mice. J Agric Food Chem. 2020;68(20):5707–5714. doi:10.1021/acs.jafc.9b08313
   PubMed Web of Science ®Google Scholar
• Guignabert C, Humbert M. Targeting transforming growth factor-β receptors in pulmonary hypertension. Eur Respir J. 2021;57(2):2002341. doi:10.1183/13993003.02341-2020
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–455. doi:10.1161/CIRCRESAHA.116.305360
   PubMed Web of Science ®Google Scholar
• El-Deeb OS, Atef MM, Hafez YM. The interplay between microbiota-dependent metabolite trimethylamine N-oxide, Transforming growth factor β/SMAD signaling and inflammasome activation in chronic kidney disease patients: a new mechanistic perspective. J Cell Biochem. 2019;120(9):14476–14485. doi:10.1002/jcb.28707
   PubMed Web of Science ®Google Scholar
• Frangogiannis N. Transforming growth factor-β in tissue fibrosis. J Exp Med. 2020;217(3):e20190103. doi:10.1084/jem.20190103
   PubMed Web of Science ®Google Scholar
• Kojonazarov B, Novoyatleva T, Boehm M, et al. p38 MAPK inhibition improves heart function in pressure-loaded right ventricular hypertrophy. Am J Respir Cell Mol Biol. 2017;57(5):603–614. doi:10.1165/rcmb.2016-0374OC
   PubMed Web of Science ®Google Scholar
• Chowdhury A, Sarkar J, Pramanik PK, Chakraborti T, Chakraborti S. Cross talk between MMP2-Spm-Cer-S1P and ERK1/2 in proliferation of pulmonary artery smooth muscle cells under angiotensin II stimulation. Arch Biochem Biophys. 2016;603:91–101. doi:10.1016/j.abb.2016.05.013
   PubMed Web of Science ®Google Scholar
• Sarkar J, Chakraborti T, Chowdhury A, Bhuyan R, Chakraborti S. Protective role of epigallocatechin-3-gallate in NADPH oxidase-MMP2-Spm-Cer-S1P signalling axis mediated ET-1 induced pulmonary artery smooth muscle cell proliferation. J Cell Commun Signal. 2019;13(4):473–489. doi:10.1007/s12079-018-00501-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang X, Gao L, et al. Cortistatin exerts antiproliferation and antimigration effects in vascular smooth muscle cells stimulated by Ang II through suppressing ERK1/2, p38 MAPK, JNK and ERK5 signaling pathways. Ann Transl Med. 2019;7(20):561. doi:10.21037/atm.2019.09.45
   PubMed Web of Science ®Google Scholar
• Zhu W, Gregory JC, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111–124.
   PubMed Web of Science ®Google Scholar
• Duttaroy AK. Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review. Nutrients. 2021;13(1):144. doi:10.3390/nu13010144
   PubMed Web of Science ®Google Scholar
• Bennett BJ, De Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17(1):49–60. doi:10.1016/j.cmet.2012.12.011
   PubMed Web of Science ®Google Scholar
• Ding L, Chang M, Guo Y, et al. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis. 2018;17(1):286. doi:10.1186/s12944-018-0939-6
   PubMed Web of Science ®Google Scholar
• Fang Y, Yan C, Zhao Q, et al. The roles of microbial products in the development of colorectal cancer: a review. Bioengineered. 2021;12(1):720–735. doi:10.1080/21655979.2021.1889109
   PubMed Web of Science ®Google Scholar
• Dumas ME, Rothwell AR, Hoyles L, et al. Microbial-host co-metabolites are prodromal markers predicting phenotypic heterogeneity in behavior, obesity, and impaired glucose tolerance. Cell Rep. 2017;20(1):136–148. doi:10.1016/j.celrep.2017.06.039
   PubMed Web of Science ®Google Scholar
• Guo S, Luo Y. Brain Foxp3(+) regulatory T cells can be expanded by Interleukin-33 in mouse ischemic stroke. Int Immunopharmacol. 2020;81:106027. doi:10.1016/j.intimp.2019.106027
   PubMed Web of Science ®Google Scholar
• Zhao ZH, Xin FZ, Zhou D, et al. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. World J Gastroenterol. 2019;25(20):2450–2462. doi:10.3748/wjg.v25.i20.2450
   PubMed Web of Science ®Google Scholar
• Govindarajulu M, Pinky PD, Steinke I, et al. Gut metabolite TMAO induces synaptic plasticity deficits by promoting endoplasmic reticulum stress. Front Mol Neurosci. 2020;13:138. doi:10.3389/fnmol.2020.00138
   PubMed Web of Science ®Google Scholar
• Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585–1595. doi:10.1016/j.cell.2015.11.055
   PubMed Web of Science ®Google Scholar
• Huang Y, Lin F, Tang R, et al. Gut microbial metabolite Trimethylamine N-Oxide aggravates pulmonary hypertension. Am J Respir Cell Mol Biol. 2022;66(4):452–460. doi:10.1165/rcmb.2021-0414OC
   PubMed Web of Science ®Google Scholar
• Shen X, Li L, Sun Z, et al. Gut microbiota and atherosclerosis-focusing on the plaque stability. Front Cardiovasc Med. 2021;8:668532. doi:10.3389/fcvm.2021.668532
   PubMed Web of Science ®Google Scholar
• Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013;110(11):4410–4415. doi:10.1073/pnas.1215927110
   PubMed Web of Science ®Google Scholar
• Ufnal M, Zadlo A, Ostaszewski R. TMAO: a small molecule of great expectations. Nutrition. 2015;31(11–12):1317–1323. doi:10.1016/j.nut.2015.05.006
   PubMed Web of Science ®Google Scholar
• Nøhr MK, Egerod KL, Christiansen SH, et al. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience. 2015;290:126–137. doi:10.1016/j.neuroscience.2015.01.040
   PubMed Web of Science ®Google Scholar
• Brown AJ, Goldsworthy SM, Barnes AA, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312–11319. doi:10.1074/jbc.M211609200
   PubMed Web of Science ®Google Scholar
• Tang C, Offermanns S. FFA2 and FFA3 in metabolic regulation. Handb Exp Pharmacol. 2017;236:205–220.
   PubMedGoogle Scholar
• Sun M, Wu W, Liu Z, Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017;52(1):1–8. doi:10.1007/s00535-016-1242-9
   PubMed Web of Science ®Google Scholar
• Hsu CN, Yu HR, Lin IC, et al. Sodium butyrate modulates blood pressure and gut microbiota in maternal tryptophan-free diet-induced hypertension rat offspring. J Nutr Biochem. 2022;108:109090. doi:10.1016/j.jnutbio.2022.109090
   PubMed Web of Science ®Google Scholar
• Gurav A, Sivaprakasam S, Bhutia YD, Boettger T, Singh N, Ganapathy V. Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions. Biochem J. 2015;469(2):267–278. doi:10.1042/BJ20150242
   PubMed Web of Science ®Google Scholar
• Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2015;8(1):80–93. doi:10.1038/mi.2014.44
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569–573. doi:10.1126/science.1241165
   PubMed Web of Science ®Google Scholar
• Lin MY, de Zoete MR, van Putten JP, Strijbis K. Redirection of epithelial immune responses by short-chain fatty acids through inhibition of histone deacetylases. Front Immunol. 2015;6:554. doi:10.3389/fimmu.2015.00554
   PubMed Web of Science ®Google Scholar
• Asarat M, Apostolopoulos V, Vasiljevic T, Donkor O. Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells. Int J Food Sci Nutr. 2015;66(7):755–765. doi:10.3109/09637486.2015.1088935
   PubMed Web of Science ®Google Scholar
• Yeo Y, Yi ES, Kim JM, et al. FGF12 (Fibroblast Growth Factor 12) Inhibits vascular smooth muscle cell remodeling in pulmonary arterial hypertension. Hypertension. 2020;76(6):1778–1786. doi:10.1161/HYPERTENSIONAHA.120.15068
   PubMed Web of Science ®Google Scholar
• Wu PH, Chiu YW, Zou HB, et al. Exploring the Benefit of 2-Methylbutyric acid in patients undergoing hemodialysis using a cardiovascular proteomics approach. Nutrients. 2019;11(12):3033. doi:10.3390/nu11123033
   PubMed Web of Science ®Google Scholar
• Bartolomaeus H, Balogh A, Yakoub M, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139(11):1407–1421. doi:10.1161/CIRCULATIONAHA.118.036652
   PubMed Web of Science ®Google Scholar
• Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137–174. doi:10.1146/annurev.biochem.72.121801.161712
   PubMed Web of Science ®Google Scholar
• Chambers KF, Day PE, Aboufarrag HT, Kroon PA. Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review. Nutrients. 2019;11(11):2588. doi:10.3390/nu11112588
   PubMed Web of Science ®Google Scholar
• Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res. 2015;56(6):1085–1099. doi:10.1194/jlr.R054114
   PubMed Web of Science ®Google Scholar
• Xu G, Pan LX, Li H, et al. Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated. Am J Physiol Gastrointest Liver Physiol. 2004;286(5):G730–735. doi:10.1152/ajpgi.00397.2003
   PubMed Web of Science ®Google Scholar
• Chen P, Zhang R, Mou L, Li X, Qin Y, Li X. An impaired hepatic clock system effects lipid metabolism in rats with nephropathy. Int J Mol Med. 2018;42(5):2720–2736. doi:10.3892/ijmm.2018.3833
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Chen J, Cooper AD. Regulation of cholesterol 7 alpha-hydroxylase gene expression in Hep-G2 cells. Effect of serum, bile salts, and coordinate and noncoordinate regulation with other sterol-responsive genes. J Biol Chem. 1994;269(13):10071–10078. doi:10.1016/S0021-9258(17)36991-0
   PubMed Web of Science ®Google Scholar
• Li T, Francl JM, Boehme S, Chiang JY. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice. Hepatology. 2013;58(3):1111–1121. doi:10.1002/hep.26427
   PubMed Web of Science ®Google Scholar
• Song KH, Li T, Owsley E, Chiang JY. A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. J Lipid Res. 2010;51(8):2223–2233. doi:10.1194/jlr.M004531
   PubMed Web of Science ®Google Scholar
• Yokota A, Fukiya S, Islam KB, et al. Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes. 2012;3(5):455–459. doi:10.4161/gmic.21216
   PubMed Web of Science ®Google Scholar
• Desai MS, Mathur B, Eblimit Z, et al. Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology. 2017;65(1):189–201. doi:10.1002/hep.28890
   PubMed Web of Science ®Google Scholar
• Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–585. doi:10.1038/nm.3145
   PubMed Web of Science ®Google Scholar
• Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome. 2020;8(1):36. doi:10.1186/s40168-020-00821-0
   PubMed Web of Science ®Google Scholar
• Levi M. Role of bile acid-regulated nuclear receptor FXR and G protein-coupled receptor TGR5 in regulation of cardiorenal syndrome (Cardiovascular Disease and Chronic Kidney Disease). Hypertension. 2016;67(6):1080–1084. doi:10.1161/HYPERTENSIONAHA.115.06417
   PubMed Web of Science ®Google Scholar
• Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res. 2012;53(9):1723–1737. doi:10.1194/jlr.R024794
   PubMed Web of Science ®Google Scholar
• Comeglio P, Morelli A, Adorini L, Maggi M, Vignozzi L. Beneficial effects of bile acid receptor agonists in pulmonary disease models. Expert Opin Investig Drugs. 2017;26(11):1215–1228. doi:10.1080/13543784.2017.1385760
   PubMed Web of Science ®Google Scholar
• Nemet I, Saha PP, Gupta N, et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180(5):862–877.e822. doi:10.1016/j.cell.2020.02.016
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang S, Wu J, et al. Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin Chim Acta. 2020;507:236–241. doi:10.1016/j.cca.2020.04.037
   PubMed Web of Science ®Google Scholar
• Huynh K. Novel gut microbiota-derived metabolite promotes platelet thrombosis via adrenergic receptor signalling. Nat Rev Cardiol. 2020;17(5):265. doi:10.1038/s41569-020-0367-y
   PubMed Web of Science ®Google Scholar
• Fang C, Zuo K, Fu Y, et al. Dysbiosis of gut microbiota and metabolite phenylacetylglutamine in coronary artery disease patients with stent stenosis. Front Cardiovasc Med. 2022;9:832092. doi:10.3389/fcvm.2022.832092
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003
   PubMed Web of Science ®Google Scholar
• Liu JR, Miao H, Deng DQ, Vaziri ND, Li P, Zhao YY. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation. Cell Mol Life Sci. 2021;78(3):909–922. doi:10.1007/s00018-020-03645-1
   PubMed Web of Science ®Google Scholar
• Niinisalo P, Oksala N, Levula M, et al. Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study. Ann Med. 2010;42(1):55–63. doi:10.3109/07853890903321559
   PubMed Web of Science ®Google Scholar
• Song P, Ramprasath T, Wang H, Zou MH. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Cell Mol Life Sci. 2017;74(16):2899–2916. doi:10.1007/s00018-017-2504-2
   PubMed Web of Science ®Google Scholar
• Sanchez-Gimenez R, Ahmed-Khodja W, Molina Y, et al. Gut microbiota-derived metabolites and cardiovascular disease risk: a systematic review of prospective cohort studies. Nutrients. 2022;14(13):2654. doi:10.3390/nu14132654
   PubMed Web of Science ®Google Scholar
• Barreto FC, Barreto DV, Liabeuf S, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4(10):1551–1558. doi:10.2215/CJN.03980609
   PubMed Web of Science ®Google Scholar
• Koike H, Morita T, Tatebe J, et al. The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction. Heart Vessels. 2019;34(4):641–649. doi:10.1007/s00380-018-1288-0
   PubMed Web of Science ®Google Scholar
• Dou L, Jourde-Chiche N, Faure V, et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost. 2007;5(6):1302–1308. doi:10.1111/j.1538-7836.2007.02540.x
   PubMed Web of Science ®Google Scholar
• Huć T, Nowinski A, Drapala A, Konopelski P, Ufnal M. Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats. Pharmacol Res. 2018;130:172–179. doi:10.1016/j.phrs.2017.12.025
   PubMed Web of Science ®Google Scholar
• Imazu M, Fukuda H, Kanzaki H, et al. Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure. Sci Rep. 2020;10(1):16528. doi:10.1038/s41598-020-73633-9
   PubMed Web of Science ®Google Scholar
• Metghalchi S, Ponnuswamy P, Simon T, et al. Indoleamine 2,3-Dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of Interleukin-10 production. Cell Metab. 2015;22(3):460–471. doi:10.1016/j.cmet.2015.07.004
   PubMed Web of Science ®Google Scholar
• Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, et al. The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases. Nutrients. 2020;12(3):605. doi:10.3390/nu12030605
   PubMed Web of Science ®Google Scholar